Chart calendar Genmab A/S

f5615281a5e54c0d21e.EplyFkTx8RAGEDFrcsXiEpKSexWNJ1gWhS75P9Cez_I.R8ohdR2ThVNhfQUEIoyxWvzaIl3HVywlymysCZfm_cpj-yVdL9yzZmoiCQ~57ce80de300723d1e84a8c6dfb102ee6

Upcoming events on Genmab A/S

11/12/2025

R&D Day

04/02/2026

Q4 2025 Earnings Release

18/03/2026

Annual General Meeting

06/05/2026

Q1 2026 Earnings Release

05/08/2026

Q2 2026 Earnings Release

04/11/2026

Q3 2026 Earnings Release

23/02/2027

Q4 2026 Earnings Release (Projected)

11/05/2027

Q1 2027 Earnings Release (Projected)

11/08/2027

Q2 2027 Earnings Release (Projected)

09/11/2027

Q3 2027 Earnings Release (Projected)

Past events on Genmab A/S

08/12/2025

American Society of Hematology Meeting - Abstract No:5513

08/12/2025

American Society of Hematology Meeting - Abstract No:5357

08/12/2025

American Society of Hematology Meeting - Abstract No:5370

08/12/2025

American Society of Hematology Meeting - Abstract No:5393

08/12/2025

American Society of Hematology Meeting - Abstract No:5511

08/12/2025

American Society of Hematology Meeting - Abstract No:1017

08/12/2025

American Society of Hematology Meeting - Abstract No:1015

07/12/2025

American Society of Hematology Meeting - Abstract Number:3565

07/12/2025

American Society of Hematology Meeting - Abstract No:4481

07/12/2025

American Society of Hematology Meeting - Abstract No:3566

07/12/2025

American Society of Hematology Meeting - Abstract No:3736

07/12/2025

American Society of Hematology Meeting - Abstract No:466

07/12/2025

American Society of Hematology Meeting - Abstract No:465

07/12/2025

American Society of Hematology Meeting - Abstract No:464

06/12/2025

American Society of Hematology Meeting - Abstract No:3565

06/12/2025

American Society of Hematology Meeting - Abstract No:2721

06/12/2025

American Society of Hematology Meeting - Abstract No:1960

06/12/2025

American Society of Hematology Meeting - Abstract No:1959

06/12/2025

American Society of Hematology Meeting - Abstract No:1955

06/12/2025

American Society of Hematology Meeting - Abstract No:1820

Annual results

Fiscal PeriodDecember 2022 2023 2024 2025 2026 2027
Net sales
Million DKK
Released
Forecast
Spread
14 595
14 068
3.75%
16 474
16 380
0.58%
21 526
21 279
1.16%

23 898


27 609


31 839

EBITDA
Million DKK
Released
Forecast
Spread
6 719
6 371
5.46%
5 616
5 721
-1.83%
7 116
6 933
2.64%

8 984


10 158


12 866

EBIT
Million DKK
Released
Forecast
Spread
6 357
6 008
5.81%
5 321
5 398
-1.42%
7 003
6 441
8.72%

8 451


8 887


11 242

Earnings before Tax (EBT)
Million DKK
Released
Forecast
Spread
7 035
8 905
-21%
5 637
6 236
-9.6%
9 164
7 451
22.98%

9 486


8 893


11 311

Net income
Million DKK
Released
Forecast
Spread
5 522
6 793
-18.71%
4 352
4 989
-12.77%
7 844
5 544
41.48%

7 497


6 698


9 246

EPS
DKK
Released
Forecast
Spread
83,7
103
-18.98%
66,0
76,1
-13.23%
121
85,7
41.66%

117


100


132

Announcement Date22/02/2314/02/2412/02/25-

Quarterly results

Fiscal PeriodJune 2023 Q4 2024 Q1 2024 Q2 2024 S1 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4 2026 Q1 2026 Q2 2026 Q3 2026 Q4
Net sales
Million DKK
Released
Forecast
Spread
4 678
4 610
1.48%
4 143
3 989
3.86%
5 402
4 959
8.94%
9 545
9 039
5.6%
5 540
5 646
-1.89%
6 441
6 391
0.79%
4 731
5 019
-5.73%
5 934
5 812
2.11%
6 613
6 373
3.77%

6 579


6 133


6 800


7 334


7 213

EBITDA
Million DKK
Released
Forecast
Spread
1 899
1 804
5.28%
823
880
-6.45%
1 804
1 571
14.84%
2 627
2 412
8.91%
2 129
1 847
15.25%
2 275
1 966
15.72%
1 350
986
36.95%
2 412
2 207
9.32%
3 087
2 871
7.51%

2 301


2 809


3 240


4 215




EBIT
Million DKK
Released
Forecast
Spread
1 670
1 772
-5.73%
801
832
-3.68%
1 640
1 599
2.57%
2 441
2 229
9.51%
2 102
1 782
17.95%
2 191
1 945
12.67%
1 244
1 069
16.32%
2 310
2 074
11.36%
2 970
2 445
21.46%

2 212


2 334


2 782


3 773




Earnings before Tax (EBT)
Million DKK
Released
Forecast
Spread
926
1 888
-50.95%
1 716
1 064
61.28%
2 127
1 847
15.15%
3 843
3 374
13.9%
1 719
1 761
-2.38%
3 602
2 037
76.79%
1 615
1 214
32.96%
2 714
2 174
24.81%
3 119
2 491
25.22%

2 284













Net income
Million DKK
Released
Forecast
Spread
640
1 439
-55.52%
1 325
833
59.07%
1 408
1 426
-1.28%
2 733
2 598
5.2%
1 266
1 373
-7.77%
3 845
1 606
139.45%
1 290
1 068
20.84%
2 156
1 657
30.06%
2 595
1 927
34.67%

1 679


1 294


1 423


1 566


1 765

EPS
DKK
Released
Forecast
Spread
9,67
22,3
-56.65%
20,2
12,9
56.06%
21,7
21,8
-0.34%
41,9
39,5
5.92%
19,8
21,3
-6.93%
59,6
25,0
138.85%
20,2
16,0
26.14%
34,8
24,5
42.1%
41,8
30,3
37.77%

27,4


14,8


14,6


20,7


22,6

Announcement Date14/02/2402/05/2408/08/2408/08/2406/11/2412/02/2508/05/2507/08/2506/11/25-----
14/12/2025

Q3 2025 Earnings Release

14/01/2026

Q3 2026 Earnings Release (Projected)

04/02/2026

Q4 2025 Earnings Release

04/02/2026

Q1 2026 Earnings Release (Projected)

09/02/2026

Q4 2025 Earnings Release (Projected)

09/02/2026

Q1 2026 Earnings Release (Projected)

10/02/2026

Q4 2025 Earnings Release (Projected)

10/02/2026

Q2 2026 Earnings Release (Projected)

11/02/2026

Q4 2025 Earnings Release (Projected)

11/02/2026

Q4 2025 Earnings Release (Projected)

More events

Past sector events for Genmab A/S

08/12/2025

November 2025 Sales and Revenue Release

05/12/2025

November 2025 Sales and Revenue Release

05/12/2025

November 2025 Sales and Revenue Release

04/12/2025

Q3 2025 Earnings Release

03/12/2025

Q2 2026 Earnings Release (Projected)

25/11/2025

Q4 2025 Earnings Release

21/11/2025

Q3 2025 Sales and Revenue Release

17/11/2025

Q3 2025 Earnings Release

14/11/2025

Q3 2025 Earnings Release

13/11/2025

Q3 2025 Earnings Release

Quarterly revenue - Rate of surprise

Net sales - Rate of surprise

Annual profits - Rate of surprise